Daratumumab-a novel treatment strategy in relapsed/refractory acute leukemia. | Ann Hematol;102(11): 3291-3293, 2023 Nov. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL CLAP/WR-PAHO/WHO

Latin-American Center for Perinatology, Woman and Reproductive Health

Subject descriptor lookup Advanced Search

Daratumumab-a novel treatment strategy in relapsed/refractory acute leukemia.

Borah, Pronamee; Dayal, Nitin; Pathak, Sangeeta; Naithani, Rahul.

Affiliation

Borah P; Department of Hematology and Bone Marrow Transplant, Paras Health, Gurugram, 122002, India.
Dayal N; Department of Lab Medicine, Max Superspecialty Hospital, Delhi, India.
Pathak S; Department of Transfusion Medicine, Max Superspecialty Hospital, Delhi, India.
Naithani R; Department of Hematology and Bone Marrow Transplant, Paras Health, Gurugram, 122002, India. dr_rahul6@hotmail.com.

Ann Hematol ; 102(11): 3291-3293, 2023 Nov.

Article in En | MEDLINE | ID: mdl-37558803

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2023 Type: Article Affiliation country: India

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2023 Type: Article Affiliation country: India